Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo library.
Key information
Latest press releases
- SHINGRIX approved in Canada for adults at increased risk of shingles due to immunodeficiency or immunosuppression
- For the third consecutive year in a row GSK is named one of Canada’s Top 100 Employers
- NUCALA (mepolizumab) the first and only anti-IL-5 add-on treatment approved in Canada that targets eosinophilic inflammation in adults with chronic rhinosinusitis with nasal polyps (CRSwNP)
- VOLUNTARILY RECALL OF TUMS EXTRA STRENGTH (750MG) ASSORTED BERRY 100CT AND ROLL 3X8CT
Media contacts
If you are a member of the Canadian media and you require more information from GlaxoSmithKline Inc., please contact Corporate Communications at 905-819-3363.
The telephone number above is for media enquiries only. To contact the Mississauga office switchboard, please call 905-819-3000 or visit our Contact Us page on this site.
-
GSK in Canada
GSK has a history in Canada that dates back to 1902
-
Our prescription medicines
Our pharmaceuticals business discovers, develops and makes medicines to treat a broad range of the most common acute and chronic diseases
-
Our vaccines
Our vaccines business develops, produces and distributes around 2 million vaccines every day to people across over 160 countries
-
Our consumer healthcare products
When experiencing discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products will help you enjoy again.
